Recognition of risk for clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy

Clinical Infectious Diseases

Volumn 50, Issue 10, 2010, Pages 1419-1421

  Evans Jones, John G ^a   Cottle, Lucy E ^a   Back, David J ^b   Gibbons, Sara ^b   Beeching, Nicholas J ^a   Carey, Peter B ^a   Khoo, Saye H ^a,b  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; DARUNAVIR; FOSAMPRENAVIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOPINAVIR; PROTEINASE INHIBITOR; RECREATIONAL DRUG; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG INTERACTIONS; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 77951815650     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/652149     Document Type: Article

References (10)

1. Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis 2006; 43: 933-938. (Pubitemid 44435525)
2. Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy 2007; 27(10); 1379-1386. (Pubitemid 47530444)
3. Shah S, McGowan J, Opulski B, et al. Identification of drug interactions involving ART in New York City HIV specialty clinics. In Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA; Foundation for Retrovirology and Human Health, 2007. Abstract 573.
4. Kigen G, Kimaiyo S, Back D, et al. Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya. In: Program and abstracts of the Ninth International Congress on Drug Therapy in HIV Infection. Geneva, Switzerland: The International AIDS Society, 2008. Abstract 0122.
5. de Maat MM, de Boer A, Koks CH, et al. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther 2004; 29(2): 121-130.
6. Couris RR, Tataronis GR, Dallai GE, Blumberg JB, Dwyer JT. Assessment of healthcare professionals' knowledge about warfarin-vitamin K drug-nutrient interactions. J Am Coll Nutr 2000; 19(4): 439-445.
7. Liverpool HIV Drug Interactions Web site. http://www.hiv- druginteractions.org. Accessed 31 October 2008.
8. Summary of Product Characteristics. Electronic Medicines Compendium. http://www.emc.medicines.org.uk. Accessed 31 October 2008.
9. de Maat MM, Frankfort SV, Mathôt RA, et al. Discrepancies between medical, and pharmacy records for patients on anti-HIV drugs. Ann Pharmacother 2002; 36(3): 410-1115
10. Eslami S, Abu-Hanna A, de Keizer NF. Evaluation of outpatient computerized physician medication order entry systems: a systematic review. J Am Med Inform Assoc 2007; 14(4): 400-406.